MedTrace Logo

Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.

NCT01687010 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2012-09-18

No results posted yet for this study

Summary

Sepsis is a common cause for morbidity and mortality in critically ill patients. With the development of medical skills, the mortality is still remain very high. Inappropriateness of initial antibiotic treatment is an important risk factor for mortality and effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. However, the early treatment based on early diagnosis.But it is very difficult to diagnosis because of lack of specific clinic symptom and sign.When severe sepsis occur, biomarker could be helpful to diagnosis. Unfortunately, the diagnostic value of single biomarker is limited. Therefore, combine several biomarkers could enhance the diagnostic value.

Conditions

  • Diagnostic and Predictive Value

Sponsors & Collaborators

  • Southeast University, China

    collaborator OTHER

  • Jianfeng Xie

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Completion
2012-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01687010 on ClinicalTrials.gov